Prescription drug · NDA
Furosemide NDC 51655-481
Furosemide 20 mg/1 · Tablet · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51655-481-52 | 51655048152 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-481-52)Marketed from Nov 19, 2020 | |
| 51655-481-53 | 51655048153 | 10 TABLET in 1 BOTTLE, PLASTIC (51655-481-53)Marketed from Nov 30, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Furosemide
- Generic name (nonproprietary)
- furosemide
- Active ingredients
- Furosemide — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018823
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis at Loop of Henle (Physiologic effect)
- Identifiers
- Product ID 51655-481_4b815690-53fa-6a41-e063-6394a90ad03fSPL ID 4b815690-53fa-6a41-e063-6394a90ad03fSPL set ID f3173c0d-2b62-7c7b-e053-2995a90ada05RxCUI 310429UNII 7LXU5N7ZO5
- Pharmacologic class
- Loop Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451655048152followed by a unit qualifier and the quantityPackage 51655-0481-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 018823
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Furosemide | Furosemide 40 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-069 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-4299 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-747 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-8297 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | A-S Medication Solutions | 50090-6219 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-8299 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-4297 |